메뉴 건너뛰기
Neurology
Volumn 46, Issue 3, 1996, Pages 822-824
Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma
Author keywords

[No Author keywords available]
Indexed keywords

MEMBRANE ANTIGEN;
EID: 0029875710     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.3.822     Document Type: Article
Times cited : (70)
References (10)
  • 1
    • 0024409871 scopus 로고
    • Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features
    • Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989; 12:435-451.
    • (1989) Muscle Nerve , vol.12 , pp. 435-451
    • Albers, J.W.1    Kelly, J.J.2
  • 2
    • 0023032004 scopus 로고
    • Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells
    • Noronha AB, Harper JR, Ilyas AA, Reisfeld RA, Quarles RH. Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells. J Neurochem 1986; 47:1558-1565.
    • (1986) J Neurochem , vol.47 , pp. 1558-1565
    • Noronha, A.B.1    Harper, J.R.2    Ilyas, A.A.3    Reisfeld, R.A.4    Quarles, R.H.5
  • 5
    • 0026785589 scopus 로고
    • Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma
    • Saleh MN, Khazaeli MB, Wheeler RH, et al. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res 1992; 52:4342-4347.
    • (1992) Cancer Res , vol.52 , pp. 4342-4347
    • Saleh, M.N.1    Khazaeli, M.B.2    Wheeler, R.H.3
  • 6
    • 0028027690 scopus 로고
    • Demyelinating neuropathy triggered by melanoma immunotherapy
    • Fuller GN, Spies JM, Pollard JD, McLeod JG. Demyelinating neuropathy triggered by melanoma immunotherapy. Neurology 1994; 44:2404-2405.
    • (1994) Neurology , vol.44 , pp. 2404-2405
    • Fuller, G.N.1    Spies, J.M.2    Pollard, J.D.3    McLeod, J.G.4
  • 7
    • 0024473651 scopus 로고
    • Antibodies to GM1 and GD1 in patients with motor neuron disease without plasma cell dyscrasia
    • Shy ME, Evans VA, Lublin FD, et al. Antibodies to GM1 and GD1 in patients with motor neuron disease without plasma cell dyscrasia. Ann Neurol 1989; 25:511-513.
    • (1989) Ann Neurol , vol.25 , pp. 511-513
    • Shy, M.E.1    Evans, V.A.2    Lublin, F.D.3
  • 8
    • 0020537892 scopus 로고
    • Anti-MAG IgM antibodies in patients with neuropathy and IgM M-proteins: Detection by ELISA
    • Nobile-Orozio E, Vierotisz T, Messito MJ, Sherman WH, Latov N. Anti-MAG IgM antibodies in patients with neuropathy and IgM M-proteins: detection by ELISA. Neurology 1983; 33:939-942.
    • (1983) Neurology , vol.33 , pp. 939-942
    • Nobile-Orozio, E.1    Vierotisz, T.2    Messito, M.J.3    Sherman, W.H.4    Latov, N.5
  • 9
    • 0024445359 scopus 로고
    • Regional and systemic strategies for metastatic malignant melanoma
    • Creagan ET. Regional and systemic strategies for metastatic malignant melanoma. Mayo Clin Proc 1989; 64:852-860.
    • (1989) Mayo Clin Proc , vol.64 , pp. 852-860
    • Creagan, E.T.1
  • 10
    • 0023262933 scopus 로고
    • Prognostic significance of hypopigmentation in malignant melanoma
    • Bystryn JC, Rigel D, Friedman RJ, Kopf A. Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol 1987; 123:1053-1055.
    • (1987) Arch Dermatol , vol.123 , pp. 1053-1055
    • Bystryn, J.C.1    Rigel, D.2    Friedman, R.J.3    Kopf, A.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.